The cardioprotective role of beta-blockers in patients with diabetes mellitus.

The cardioprotective role of beta-blockers in patients with diabetes mellitus.

This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Landray, M, Toescu, V, Kendall, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2002

Gelijkaardige items

Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
door: A T Teplyakov, et al.
Gepubliceerd in: (2009-03-01)

Cardioprotective role of oleanolic acid in patients with type 2 diabetes mellitus
door: Chengrui Li, et al.
Gepubliceerd in: (2024-06-01)

Hypoglycemia with Beta-Blocker in Patients with Type II Diabetes
door: Rehmat Wali, et al.
Gepubliceerd in: (2023-07-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
door: M. A. Maksimova, et al.
Gepubliceerd in: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
door: M. A. Maksimova, et al.
Gepubliceerd in: (2015-09-01)

The role of beta blockers in open angle glaucoma
door: Marmion V
Gepubliceerd in: (1982-01-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
door: A. A. Aleksandrov, et al.
Gepubliceerd in: (2016-01-01)

Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection
door: Elena Nikolaevna Trunina, et al.
Gepubliceerd in: (2011-06-01)

A systematic review and meta-analysis of the effects of diuretics and beta-blockers on glycaemic control in diabetes mellitus
door: Hirst, J, et al.
Gepubliceerd in: (2014)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
door: A. A. Taylor, et al.
Gepubliceerd in: (2011-08-01)

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
door: Wai Bryan, et al.
Gepubliceerd in: (2012-02-01)

Metabolomics of beta-blockers
door: Tan, Ian Yong Ming.
Gepubliceerd in: (2010)

The discovery of beta-blockers
door: Subir Kumar Maulik
Gepubliceerd in: (2018-01-01)

Beta-blockers in cardiac failure.
door: Neubauer, G, et al.
Gepubliceerd in: (1994)

The Place for Calcium Channel Blockers in the Treatment of Hypertension in Patients with Diabetes Mellitus
door: Tarif Nauman, et al.
Gepubliceerd in: (2000-01-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
door: Ol'ga Konstantinovna Vikulova, et al.
Gepubliceerd in: (2009-09-01)

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
door: Robin Lengton, et al.
Gepubliceerd in: (2022-08-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
door: R. I. Striuk, et al.
Gepubliceerd in: (2015-12-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
door: R. I. Striuk, et al.
Gepubliceerd in: (2015-12-01)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
door: Roberto F.E. Pedretti
Gepubliceerd in: (2018-06-01)

Outcomes of beta-blocker pharmacotherapy in patients with heart failure
door: Maletin Sanja D., et al.
Gepubliceerd in: (2024-01-01)

Role of liquid membrane hypothesis in the biological actions of beta-blockers
door: Nagappa, A., et al.
Gepubliceerd in: (2003)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
door: I. T. Murkamilov, et al.
Gepubliceerd in: (2017-07-01)

Considerations for choosing of beta-blockers
door: Zoltán Nádházi
Gepubliceerd in: (2024-10-01)

Beta-blockers and the criteria of SIRS
door: W Kittisupamongkol
Gepubliceerd in: (2009-01-01)

Beta adrenergic blockers poisoning
door: Tadić Milorad, et al.
Gepubliceerd in: (2016-01-01)

beta blockers in hypertension Reply
door: Rothwell, P
Gepubliceerd in: (2010)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
door: I V Fomin, et al.
Gepubliceerd in: (2017-12-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
door: Fomin I.V., et al.
Gepubliceerd in: (2017-09-01)

Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus
door: M.D. Ivanova, et al.
Gepubliceerd in: (2015-04-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
door: A. G. Arutyunov, et al.
Gepubliceerd in: (2022-01-01)

Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
door: Yu. V. Lapina, et al.
Gepubliceerd in: (2008-08-01)

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis
door: S. N. Shilov, et al.
Gepubliceerd in: (2021-05-01)

Beta-blockers in modern glaucoma therapy. Review
door: O. A. Kiseleva, et al.
Gepubliceerd in: (2014-07-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
door: A. V. Simanenkova, et al.
Gepubliceerd in: (2021-07-01)

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
door: A. O. Konradi, et al.
Gepubliceerd in: (2018-12-01)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
door: Heirim Lee, et al.
Gepubliceerd in: (2022-10-01)

Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
door: Haddiya I, et al.
Gepubliceerd in: (2023-10-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
door: Kazufumi Nakamura, et al.
Gepubliceerd in: (2011-08-01)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
door: Tilman Sauerbruch, et al.
Gepubliceerd in: (2023-01-01)